Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 335

1.

Restoring Blood Supply to the Heart While Replacing the Lungs: Is It Worth the Risk?

Raemdonck DV, Vos R, Cleemput JV, Rega F, Rex S, Neyrinck A, Verleden GM.

Transplantation. 2019 Feb 18. doi: 10.1097/TP.0000000000002610. [Epub ahead of print] No abstract available.

PMID:
30801520
2.

Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival.

Yang JYC, Verleden SE, Zarinsefat A, Vanaudenaerde BM, Vos R, Verleden GM, Sarwal RD, Sigdel TK, Liberto JM, Damm I, Watson D, Sarwal MM.

J Clin Med. 2019 Feb 13;8(2). pii: E241. doi: 10.3390/jcm8020241.

3.

Double-lung versus heart-lung transplantation for precapillary pulmonary arterial hypertension: a 24-year single-center retrospective study.

Brouckaert J, Verleden SE, Verbelen T, Coosemans W, Decaluwé H, De Leyn P, Depypere L, Nafteux P, Van Veer H, Meyns B, Rega F, Van De Velde M, Poortmans G, Rex S, Neyrinck A, Van den Berghe G, Vlasselaers D, Van Cleemput J, Budts W, Vos R, Quarck R, Belge C, Delcroix M, Verleden GM, Van Raemdonck D.

Transpl Int. 2019 Feb 8. doi: 10.1111/tri.13409. [Epub ahead of print]

PMID:
30735591
4.

Phenotypical diversity of airway morphology in chronic lung graft vs. host disease after stem cell transplantation.

Verleden SE, McDonough JE, Schoemans H, Knoop C, Verschakelen J, Dubbeldam A, Boone MN, Van Hoorebeke L, Verbeken E, Weynand B, Van Raemdonck D, Verleden GM, Vos R, Vanaudenaerde BM.

Mod Pathol. 2019 Feb 5. doi: 10.1038/s41379-019-0203-2. [Epub ahead of print]

PMID:
30723292
5.

Azithromycin and early allograft function after lung transplantation: A randomized, controlled trial.

Van Herck A, Frick AE, Schaevers V, Vranckx A, Verbeken EK, Vanaudenaerde BM, Sacreas A, Heigl T, Neyrinck AP, Van Raemdonck D, Dupont LJ, Yserbyt J, Verleden SE, Verleden GM, Vos R.

J Heart Lung Transplant. 2019 Mar;38(3):252-259. doi: 10.1016/j.healun.2018.12.006. Epub 2018 Dec 14.

PMID:
30686699
6.

Montelukast in chronic lung allograft dysfunction after lung transplantation.

Vos R, Eynde RV, Ruttens D, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verbeken EK, Neyrinck AP, Van Raemdonck DE, Verleden GM; Leuven Lung Transplant Group.

J Heart Lung Transplant. 2018 Dec 6. pii: S1053-2498(18)31773-X. doi: 10.1016/j.healun.2018.11.014. [Epub ahead of print]

PMID:
30638839
7.

Successful lung transplantation for chronic Mycobacterium abscessus infection in advanced cystic fibrosis, a case series.

Raats D, Lorent N, Saegeman V, Vos R, van Ingen J, Verleden G, Van Raemdonck D, Dupont L.

Transpl Infect Dis. 2018 Dec 30:e13046. doi: 10.1111/tid.13046. [Epub ahead of print]

PMID:
30597699
8.

Evolution of Functional Exercise Capacity in Lung Transplant Patients With and Without Bronchiolitis Obliterans Syndrome: A Longitudinal Case-Control Study.

Cebrià I Iranzo MÀ, Vos R, Verleden GM, Gosselink R, Langer D.

Arch Bronconeumol. 2018 Dec 27. pii: S0300-2896(18)30447-2. doi: 10.1016/j.arbres.2018.11.003. [Epub ahead of print] English, Spanish.

9.

Effects of Corticosteroid Treatment and Antigen Avoidance in a Large Hypersensitivity Pneumonitis Cohort: A Single-Centre Cohort Study.

De Sadeleer LJ, Hermans F, De Dycker E, Yserbyt J, Verschakelen JA, Verbeken EK, Verleden GM, Wuyts WA.

J Clin Med. 2018 Dec 21;8(1). pii: E14. doi: 10.3390/jcm8010014.

10.

Freedom from chronic lung allograft dysfunction (CLAD) or CLAD-free survival: What's in a name?

Verleden GM, Verleden SE, Vos R.

J Heart Lung Transplant. 2019 Jan;38(1):1-2. doi: 10.1016/j.healun.2018.11.005. Epub 2018 Nov 15. No abstract available.

PMID:
30497817
11.

Determinants of survival in lung transplantation patients with idiopathic pulmonary fibrosis: a retrospective cohort study.

Tuyls S, Verleden SE, Wuyts WA, Yserbyt J, Vos R, Verleden GM.

Transpl Int. 2019 Apr;32(4):399-409. doi: 10.1111/tri.13382. Epub 2018 Dec 21.

PMID:
30488486
12.

Validation of a post-transplant chronic lung allograft dysfunction classification system.

Van Herck A, Verleden SE, Sacreas A, Heigl T, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verbeken EK, Neyrinck AP, Van Raemdonck D, Verleden GM, Vos R.

J Heart Lung Transplant. 2019 Feb;38(2):166-173. doi: 10.1016/j.healun.2018.09.020. Epub 2018 Oct 4.

PMID:
30391199
13.

The common rejection module in chronic rejection post lung transplantation.

Sacreas A, Yang JYC, Vanaudenaerde BM, Sigdel TK, Liberto JM, Damm I, Verleden GM, Vos R, Verleden SE, Sarwal MM.

PLoS One. 2018 Oct 5;13(10):e0205107. doi: 10.1371/journal.pone.0205107. eCollection 2018.

14.

Role of 18F-FDG PET/CT in Restrictive Allograft Syndrome After Lung Transplantation.

Verleden SE, Gheysens O, Goffin KE, Vanaudenaerde BM, Verbeken EK, Weynand B, Van Raemdonck DE, Verleden GM, Vos R.

Transplantation. 2019 Apr;103(4):823-831. doi: 10.1097/TP.0000000000002393.

PMID:
30086092
15.

Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series.

Vos R, Wuyts WA, Gheysens O, Goffin KE, Schaevers V, Verleden SE, Van Herck A, Sacreas A, Heigl T, McDonough JE, Yserbyt J, Godinas L, Dupont LJ, Neyrinck AP, Van Raemdonck DE, Verbeken EK, Vanaudenaerde BM, Verleden GM.

Am J Transplant. 2018 Dec;18(12):3045-3059. doi: 10.1111/ajt.15019. Epub 2018 Aug 17.

PMID:
30019840
16.

A role for telomere length and chromosomal damage in idiopathic pulmonary fibrosis.

McDonough JE, Martens DS, Tanabe N, Ahangari F, Verleden SE, Maes K, Verleden GM, Kaminski N, Hogg JC, Nawrot TS, Wuyts WA, Vanaudenaerde BM.

Respir Res. 2018 Jul 9;19(1):132. doi: 10.1186/s12931-018-0838-4.

17.

Clinical behaviour of patients exposed to organic dust and diagnosed with idiopathic pulmonary fibrosis.

De Sadeleer LJ, Verleden SE, De Dycker E, Yserbyt J, Verschakelen JA, Verbeken EK, Nemery B, Verleden GM, Hermans F, Vanaudenaerde BM, Wuyts WA.

Respirology. 2018 Dec;23(12):1160-1165. doi: 10.1111/resp.13342. Epub 2018 Jun 13.

PMID:
29897160
18.

Living by numbers.

Van Raemdonck D, Neyrinck A, Vos R, Verleden GM.

J Thorac Cardiovasc Surg. 2018 Aug;156(2):906-907. doi: 10.1016/j.jtcvs.2018.04.002. Epub 2018 Apr 12. No abstract available.

PMID:
29754792
19.

The aging lung: tissue telomere shortening in health and disease.

Everaerts S, Lammertyn EJ, Martens DS, De Sadeleer LJ, Maes K, van Batenburg AA, Goldschmeding R, van Moorsel CHM, Dupont LJ, Wuyts WA, Vos R, Gayan-Ramirez G, Kaminski N, Hogg JC, Janssens W, Verleden GM, Nawrot TS, Verleden SE, McDonough JE, Vanaudenaerde BM.

Respir Res. 2018 May 11;19(1):95. doi: 10.1186/s12931-018-0794-z.

20.

Lung allocation score: the Eurotransplant model versus the revised US model - a cross-sectional study.

Smits JM, Nossent G, Evrard P, Lang G, Knoop C, Kwakkel-van Erp JM, Langer F, Schramm R, van de Graaf E, Vos R, Verleden G, Rondelet B, Hoefer D, Hoek R, Hoetzenecker K, Deuse T, Strelniece A, Green D, de Vries E, Samuel U, Laufer G, Buhl R, Witt C, Gottlieb J.

Transpl Int. 2018 Aug;31(8):930-937. doi: 10.1111/tri.13262. Epub 2018 May 11.

PMID:
29665090
21.

Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.

Ruttens D, Verleden SE, Demeyer H, Van Raemdonck DE, Yserbyt J, Dupont LJ, Vanaudenaerde BM, Vos R, Verleden GM.

PLoS One. 2018 Apr 6;13(4):e0193564. doi: 10.1371/journal.pone.0193564. eCollection 2018.

22.

Diagnostic Ability of a Dynamic Multidisciplinary Discussion in Interstitial Lung Diseases: A Retrospective Observational Study of 938 Cases.

De Sadeleer LJ, Meert C, Yserbyt J, Slabbynck H, Verschakelen JA, Verbeken EK, Weynand B, De Langhe E, Lenaerts JL, Nemery B, Van Raemdonck D, Verleden GM, Wells AU, Wuyts WA.

Chest. 2018 Jun;153(6):1416-1423. doi: 10.1016/j.chest.2018.03.026. Epub 2018 Mar 30.

PMID:
29608882
23.

Multiple Solid Organ Transplantation in Telomeropathy: Case Series and Literature Review.

Lebeer M, Wuyts WA, Cassiman D, Laleman W, Nevens F, Pirenne J, Monbaliu D, Roskams T, Verbeken EK, Neyrinck AP, Van Raemdonck DE, Verleden GM, Vos R.

Transplantation. 2018 Oct;102(10):1747-1755. doi: 10.1097/TP.0000000000002198.

PMID:
29596117
24.

ISHLT Consensus Statement on adult and pediatric airway complications after lung transplantation: Definitions, grading system, and therapeutics.

Crespo MM, McCarthy DP, Hopkins PM, Clark SC, Budev M, Bermudez CA, Benden C, Eghtesady P, Lease ED, Leard L, D'Cunha J, Wigfield CH, Cypel M, Diamond JM, Yun JJ, Yarmus L, Machuzak M, Klepetko W, Verleden G, Hoetzenecker K, Dellgren G, Mulligan M.

J Heart Lung Transplant. 2018 May;37(5):548-563. doi: 10.1016/j.healun.2018.01.1309. Epub 2018 Feb 7.

PMID:
29550149
25.

Immediate post-operative broncho-alveolar lavage IL-6 and IL-8 are associated with early outcomes after lung transplantation.

Verleden SE, Martens A, Ordies S, Neyrinck AP, Van Raemdonck DE, Verleden GM, Vanaudenaerde BM, Vos R.

Clin Transplant. 2018 Apr;32(4):e13219. doi: 10.1111/ctr.13219. Epub 2018 Feb 23.

PMID:
29405435
26.

Prevention of chronic rejection after lung transplantation.

Van Herck A, Verleden SE, Vanaudenaerde BM, Verleden GM, Vos R.

J Thorac Dis. 2017 Dec;9(12):5472-5488. doi: 10.21037/jtd.2017.11.85. Review.

27.

Recipient selection process and listing for lung transplantation.

Verleden GM, Dupont L, Yserbyt J, Schaevers V, Van Raemdonck D, Neyrinck A, Vos R.

J Thorac Dis. 2017 Sep;9(9):3372-3384. doi: 10.21037/jtd.2017.08.90. Review.

28.

Toronto bridges to successful lung transplantation.

Van Raemdonck D, Neyrinck A, Vos R, Verleden GM.

J Thorac Cardiovasc Surg. 2018 Mar;155(3):1329-1330. doi: 10.1016/j.jtcvs.2017.10.103. Epub 2017 Nov 7. No abstract available.

PMID:
29198806
29.

Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation.

Verleden SE, Vanaudenaerde BM, Emonds MP, Van Raemdonck DE, Neyrinck AP, Verleden GM, Vos R.

Eur Respir J. 2017 Nov 16;50(5). pii: 1701248. doi: 10.1183/13993003.01248-2017. Print 2017 Nov.

PMID:
29146602
30.

How Would You Grade Our Progress in Primary Graft Dysfunction after Lung Transplantation?

Neyrink A, Verleden GM.

Am J Respir Crit Care Med. 2018 Jan 15;197(2):155-157. doi: 10.1164/rccm.201709-1952ED. No abstract available.

PMID:
29048930
31.

Feasibility of diaphragm pacing in patients after bilateral lung transplantation.

Testelmans D, Nafteux P, Van Cromphaut S, Vrijsen B, Vos R, De Leyn P, Decaluwé H, Van Raemdonck D, Verleden GM, Buyse B.

Clin Transplant. 2017 Dec;31(12). doi: 10.1111/ctr.13134. Epub 2017 Oct 26.

PMID:
28990225
32.

Chronic lung allograft dysfunction phenotypes and treatment.

Verleden SE, Vos R, Vanaudenaerde BM, Verleden GM.

J Thorac Dis. 2017 Aug;9(8):2650-2659. doi: 10.21037/jtd.2017.07.81. Review.

33.

Solid Organ Transplantation in Sarcoidosis.

Yserbyt J, Wuyts WA, Verleden SE, Verleden GM, Van Raemdonck DE, Verbeken EK, Vanaudenaerde BM, Vos R.

Semin Respir Crit Care Med. 2017 Aug;38(4):538-545. doi: 10.1055/s-0037-1602383. Epub 2017 Jul 27. Review. No abstract available.

PMID:
28750467
34.

Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model.

Martens A, Ordies S, Vanaudenaerde BM, Verleden SE, Vos R, Van Raemdonck DE, Verleden GM, Roobrouck VD, Claes S, Schols D, Verbeken E, Verfaillie CM, Neyrinck AP.

Stem Cell Res Ther. 2017 Jul 5;8(1):159. doi: 10.1186/s13287-017-0603-5.

35.

Statins in lung transplantation: A treatment option for every patient?

Verleden GM, Vos R.

J Heart Lung Transplant. 2017 Sep;36(9):936-937. doi: 10.1016/j.healun.2017.05.027. Epub 2017 May 25. No abstract available.

PMID:
28599875
36.

A New Step in the Marathon of Understanding Chronic Rejection after Lung Transplantation.

Vanaudenaerde B, Verleden S, Neyrinck A, Verleden G, Vos R.

Am J Respir Cell Mol Biol. 2017 Jun;56(6):683-684. doi: 10.1165/rcmb.2017-0060ED. No abstract available.

PMID:
28569594
37.

A retrospective database analysis to evaluate the potential of ex vivo lung perfusion to recruit declined lung donors.

Martens A, Van Raemdonck DE, Smits J, Verleden SE, Vos R, Vanaudenaerde BM, Verleden GM, Degezelle K, Desschans B, Neyrinck AP.

Transpl Int. 2017 Oct;30(10):1002-1010. doi: 10.1111/tri.12990. Epub 2017 Jul 13.

38.

A porcine ex vivo lung perfusion model with maximal argon exposure to attenuate ischemia-reperfusion injury.

Martens A, Ordies S, Vanaudenaerde BM, Verleden SE, Vos R, Verleden GM, Verbeken EK, Van Raemdonck DE, Claes S, Schols D, Chalopin M, Katz I, Farjot G, Neyrinck AP.

Med Gas Res. 2017 Mar 30;7(1):28-36. doi: 10.4103/2045-9912.202907. eCollection 2017 Jan-Mar.

39.

The Effect of Immunosuppression on Airway Integrity.

Bellon H, Vandermeulen E, Verleden SE, Heigl T, Vriens H, Lammertyn E, Verlinden L, Vanhove T, Verstuyf M, Hoet P, Vos R, Verleden GM, Vanaudenaerde BM.

Transplantation. 2017 Dec;101(12):2855-2861. doi: 10.1097/TP.0000000000001809.

PMID:
28471870
40.

Endoscopic advanced imaging of the respiratory tract: exploring probe-based confocal laser endomicroscopy in emphysema.

Yserbyt J, Dooms C, Janssens W, Verleden GM.

Thorax. 2018 Feb;73(2):188-190. doi: 10.1136/thoraxjnl-2016-209746. Epub 2017 Apr 14.

PMID:
28411249
41.

Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study.

Leyssens A, Dierickx D, Verbeken EK, Tousseyn T, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verleden GM, Van Raemdonck DE, Vos R.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12983. Epub 2017 May 8.

PMID:
28383790
42.

High-dose vitamin D after lung transplantation: A randomized trial.

Vos R, Ruttens D, Verleden SE, Vandermeulen E, Bellon H, Van Herck A, Sacreas A, Heigl T, Schaevers V, Van Raemdonck DE, Verbeken EK, Neyrinck AP, Dupont LJ, Yserbyt J, Vanaudenaerde BM, Verleden GM.

J Heart Lung Transplant. 2017 Aug;36(8):897-905. doi: 10.1016/j.healun.2017.03.008. Epub 2017 Mar 8.

PMID:
28365177
43.

"White-Out" After Lung Transplantation: A Multicenter Cohort Description of Late Acute Graft Failure.

Verleden SE, Gottlieb J, Dubbeldam A, Verleden GM, Suhling H, Welte T, Vos R, Greer M.

Am J Transplant. 2017 Jul;17(7):1905-1911. doi: 10.1111/ajt.14268. Epub 2017 Apr 11.

44.

Radiological Analysis of Unused Donor Lungs: A Tool to Improve Donor Acceptance for Transplantation?

Verleden SE, Martens A, Ordies S, Heigl T, Bellon H, Vandermeulen E, Van Herck A, Sacreas A, Verschakelen J, Coudyzer W, Van Raemdonck DE, Vos R, Weynand B, Verleden GM, Vanaudenaerde B, Neyrinck A.

Am J Transplant. 2017 Jul;17(7):1912-1921. doi: 10.1111/ajt.14255. Epub 2017 Mar 30.

45.

Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients.

Vanhove T, Bouwsma H, Hilbrands L, Swen JJ, Spriet I, Annaert P, Vanaudenaerde B, Verleden G, Vos R, Kuypers DRJ.

Am J Transplant. 2017 Sep;17(9):2372-2380. doi: 10.1111/ajt.14232. Epub 2017 Apr 8.

46.

Short- and Long-term Outcomes After Lung Transplantation From Circulatory-Dead Donors: A Single-Center Experience.

Ruttens D, Martens A, Ordies S, Verleden SE, Neyrinck AP, Vos R, Boada MC, Vanaudenaerde BM, Verleden GM, Van Raemdonck D.

Transplantation. 2017 Nov;101(11):2691-2694. doi: 10.1097/TP.0000000000001678.

PMID:
28207629
47.

Efficacy of a medication adherence enhancing intervention in transplantation: The MAESTRO-Tx trial.

Dobbels F, De Bleser L, Berben L, Kristanto P, Dupont L, Nevens F, Vanhaecke J, Verleden G, De Geest S.

J Heart Lung Transplant. 2017 May;36(5):499-508. doi: 10.1016/j.healun.2017.01.007. Epub 2017 Jan 6.

PMID:
28162931
48.

Interleukin-1α induced release of interleukin-8 by human bronchial epithelial cells in vitro: assessing mechanisms and possible treatment options.

Bellon H, Vandermeulen E, Mathyssen C, Sacreas A, Verleden SE, Heigl T, Vriens H, Lammertyn E, Pilette C, Hoet P, Vos R, Vanaudenaerde BM, Verleden GM.

Transpl Int. 2017 Apr;30(4):388-397. doi: 10.1111/tri.12915. Epub 2017 Mar 2.

49.

Lung cancer: a rare indication for, but frequent complication after lung transplantation.

Van Raemdonck D, Vos R, Yserbyt J, Decaluwe H, De Leyn P, Verleden GM.

J Thorac Dis. 2016 Nov;8(Suppl 11):S915-S924. Review.

50.

Immunological diversity in phenotypes of chronic lung allograft dysfunction: a comprehensive immunohistochemical analysis.

Vandermeulen E, Lammertyn E, Verleden SE, Ruttens D, Bellon H, Ricciardi M, Somers J, Bracke KR, Van Den Eynde K, Tousseyn T, Brusselle GG, Verbeken EK, Verschakelen J, Emonds MP, Van Raemdonck DE, Verleden GM, Vos R, Vanaudenaerde BM.

Transpl Int. 2017 Feb;30(2):134-143. doi: 10.1111/tri.12882. Epub 2016 Dec 8.

Supplemental Content

Loading ...
Support Center